The University of Rochester received a $113,670 project grant award from the Department of Health and Human Services Administration for Community Living on April 1, 2022 to support activities through September 30, 2024. The grant was awarded under the University Centers for Excellence in Developmental Disabilities Education, Research, and Service program (CFDA 93.632). Funds will support the University of Rochester's administration and operation of an interdisciplinary center providing...
This federal Project Grant award of $1,241,350.00 from the Administration on Disabilities (CFDA 93.632 - University Centers for Excellence in Developmental Disabilities Education, Research, and Service) supports the University of Rochester in providing interdisciplinary training, community services, research, and information dissemination related to developmental disabilities. The funding will enable the university to enhance the independence, productivity, and community integration of...
The University of Rochester was awarded a $1,829,300.00 Project Grant from the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from August 1, 2024 to July 31, 2027, will support advanced biomedical research focused on "Mechanistic Insight into the Airborne Hazards Exposure-Related Development of Neurological Disorders." As a leading research university, the...
The University of Rochester was awarded a $3,000,000 Cooperative Agreement under the Centers for Disease Control and Prevention's (CDC) Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945). This 5-year award, effective from September 30, 2024 to September 29, 2029, will support the University's Rochester Prevention Research Center in conducting research, implementing evidence-based interventions, and developing public health awareness strategies to prevent and control...
This Project Grant award in the amount of $308,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Rochester. The grant is funding a research project to investigate "INVESTIGATING MICROGLIAL REMODELING OF NEURAL CIRCUITS IN PREGNANCY" over a 2-year period from November 15, 2023 to November 14, 2025. The project aims to advance scientific understanding of the role of microglia, a type of immune...
The University of Rochester was awarded a $4,989,476.00 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The five-year award, running from August 2024 to March 2029, will support the university's provision of technical assistance, training, workforce development, organizational support, and targeted interventions to address HIV-related health disparities across the...
The Department of Health and Human Services National Institutes of Health Office of the Director awarded Duke University a $3,004,526 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) on April 15, 2021 to support SARS-COV-2 screening and diagnostic testing for return to K-12 schools through March 31, 2022. The grant funding will allow Duke University to provide COVID-19 testing for students and staff to facilitate the safe reopening of elementary and secondary schools in...
This federal Project Grant award of $6,292,954.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the "MONITORING AND MITIGATION OF NEUROLOGICAL INJURIES TO OPTIMIZE RESILIENCE AFTER REPETITIVE HEAD IMPACTS (MONITOR RHI)" research initiative. The grant was awarded to the University of Rochester, a leading private research institution, to conduct advanced biomedical research focused on transforming healthcare...
This $1,499,856 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program will support the University of Rochester in implementing a project titled "Trusted School Messengers Promoting Non-Mandated Vaccination". The project aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases by leveraging...
This federal Project Grant award of $266,615 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the "ROC STARR: Health and Immune Function Across the Lifespan" initiative at the University of Rochester. The primary goal is to train a diverse pool of physician-scientists to lead the development, implementation, and evaluation of new clinical approaches for diagnosing, treating, and...